These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3749063)

  • 1. Short-term and long-term modulation of the enzymatic control of mutagenic and carcinogenic metabolites.
    Oesch F
    Prog Clin Biol Res; 1986; 209A():495-506. PubMed ID: 3749063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased production of mutagenic metabolites of carcinogens by tissues from senescent rodents.
    Baird MB; Birnbaum LS
    Cancer Res; 1979 Nov; 39(11):4752-5. PubMed ID: 498103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism of carcinogens, possibilities for modulation.
    Oesch F
    Acta Pharmacol Toxicol (Copenh); 1984; 55 Suppl 2():15-33. PubMed ID: 6385619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of various enzymes in the control of mutagenic and carcinogenic metabolites derived from aromatic structures.
    Oesch F
    Toxicol Pathol; 1984; 12(4):391-6. PubMed ID: 6398501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of foreign compounds on formation and disposition of reactive metabolites.
    Oesch F
    Ciba Found Symp; 1980; 76():169-89. PubMed ID: 6161760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Problems associated with the metabolic activation of carcinogens and mutagens in short-term tests.
    Bartsch H
    Dev Toxicol Environ Sci; 1980; 8():133-47. PubMed ID: 7030701
    [No Abstract]   [Full Text] [Related]  

  • 7. 1,3-butadiene: cancer, mutations, and adducts. Part III: In vivo mutation of the endogenous hprt genes of mice and rats by 1,3-butadiene and its metabolites.
    Walker VE; Meng Q
    Res Rep Health Eff Inst; 2000 Mar; (92):89-139; discussion 141-9. PubMed ID: 10925840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism of 6-methylbenz[a]anthracene by rat liver microsomes and mutagenicity of metabolites.
    Mushtaq M; Fu PP; Miller DW; Yang SK
    Cancer Res; 1985 Sep; 45(9):4006-14. PubMed ID: 3896475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Control of ultimate mutagenic species by diverse enzymes.
    Oesch F; Doehmer J; Friedberg T; Glatt H; Oesch-Bartlomowicz B; Platt KL; Steinberg P; Utesch D; Thomas H
    Prog Clin Biol Res; 1990; 340B():49-65. PubMed ID: 2168050
    [No Abstract]   [Full Text] [Related]  

  • 10. Metabolism of genotoxic agents: control of reactive epoxides by hydrolase and transferase reactions.
    Oesch F
    IARC Sci Publ; 1984; (59):73-83. PubMed ID: 6400098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic activation of the (+)-S,S- and (-)-R,R-enantiomers of trans-11,12-dihydroxy-11,12-dihydrodibenzo[a,l]pyrene: stereoselectivity, DNA adduct formation, and mutagenicity in Chinese hamster V79 cells.
    Luch A; Seidel A; Glatt H; Platt KL
    Chem Res Toxicol; 1997 Oct; 10(10):1161-70. PubMed ID: 9348439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism of the polynuclear sulfur heterocycle benzo[b]phenanthro[2,3-d]thiophene by rodent liver microsomes: evidence for multiple pathways in the bioactivation of benzo[b]phenanthro[2,3-d]thiophene.
    Yuan ZX; Sikka HC; Munir S; Kumar A; Muruganandam AV; Kumar S
    Chem Res Toxicol; 2003 Dec; 16(12):1581-8. PubMed ID: 14680372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Metabolic activation and the mutagenic properties of carcinogenic N-nitramines in a liquid incubation test].
    KhudoleÄ­ VV; Bartsch H; Malaveille C
    Vopr Onkol; 1981; 27(12):47-51. PubMed ID: 7034364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microsomal biotransformation of benzo[ghi]perylene, a mutagenic polycyclic aromatic hydrocarbon without a "classic" bay region.
    Platt KL; Grupe S
    Chem Res Toxicol; 2005 Apr; 18(4):700-10. PubMed ID: 15833030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural elucidation of a mutagenic metabolite of 3-amino-1-methyl-5H-pyrido[4,3-b]indole.
    Yamazoe Y; Ishii K; Kamataki T; Kato R
    Drug Metab Dispos; 1981; 9(3):292-6. PubMed ID: 6113943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro metabolic activation in genotoxicity assays with mammalian cell cultures.
    Belvedere G
    Boll Chim Farm; 1985 Feb; 124(2):57-68. PubMed ID: 4015867
    [No Abstract]   [Full Text] [Related]  

  • 18. Carcinogenicity of mutagens: predictive capability of the Salmonella mutagenesis assay for rodent carcinogenicity.
    Zeiger E
    Cancer Res; 1987 Mar; 47(5):1287-96. PubMed ID: 3815340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Organ, species, and compound specificity in the metabolic activation of primary aromatic amines.
    Poupko JM; Radomski T; Santella RM; Radomski JL
    J Natl Cancer Inst; 1983 Jun; 70(6):1077-80. PubMed ID: 6574277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Xenobiotic metabolism and toxicity in primary monolayer cultures of hepatocytes.
    Holme JA
    NIPH Ann; 1985 Dec; 8(2):49-63. PubMed ID: 3908998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.